Literature DB >> 23554107

Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies.

Ronald B Postuma1, Jean-Francois Gagnon, Amélie Pelletier, Jacques Montplaisir.   

Abstract

Pathologic staging systems suggest that autonomic dysfunction may be an early manifestation of Parkinson's disease and dementia with Lewy bodies. However, direct evidence is limited, and no prospective studies have measured when autonomic dysfunction starts before disease. Patients with idiopathic rapid eye movement (REM) sleep behavior disorder are at very high risk of developing neurodegenerative synucleinopathy, providing an opportunity to directly observe the development of autonomic dysfunction from prodromal stages of neurodegeneration. Patients with idiopathic REM sleep behavior disorder were followed annually in a prospective cohort that was established in 2004. Urinary, orthostatic, erectile, and constipation symptoms and systolic blood pressure drop from lying to standing were assessed annually. Patients who eventually developed defined synucleinopathy were compared with age-matched controls. The evolution of autonomic measures was assessed with regression analysis to determine when markers first deviated from control values. Sensitivity and specificity of autonomic markers for identification of prodromal disease were calculated. Of 91 patients, 32 developed disease. In prodromal stages, there was substantial autonomic dysfunction observable at least 5 years before diagnosis. On regression analysis, autonomic dysfunction appeared to progress slowly over prodromal periods. The estimated onset of autonomic dysfunction ranged from 11 years to 20 years, and systolic drop (20.4 years) and constipation (15.3 years) had the earliest estimates. Systolic drop, erectile dysfunction, and constipation could identify disease up to 5 years before diagnosis with sensitivity ranging from 50% to 90%. By directly observing development of neurodegenerative synucleinopathy, we confirmed that autonomic dysfunction can occur early in neurodegenerative synucleinopathy, even as long as 20 years before defined disease. © 2013 Movement Disorder Society.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Year:  2013        PMID: 23554107     DOI: 10.1002/mds.25445

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  61 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.

Authors:  Luigi Ferini-Strambi; Wolfgang Oertel; Yves Dauvilliers; Ronald B Postuma; Sara Marelli; Alex Iranzo; Isabelle Arnulf; Birgit Högl; Högl Birgit; Raffaele Manni; Tomoyuki Miyamoto; Maria-Livia Fantini; Monica Puligheddu; Poul Jennum; Karel Sonka; Joan Santamaria; Marco Zucconi; Paola M V Rancoita; Smeranda Leu-Semenescu; Birgit Frauscher; Michele Terzaghi; Masayuki Miyamoto; Marcus Unger; Karin Stiasny-Kolster; Alex Desautels; Christina Wolfson; Amélie Pelletier; Jacques Montplaisir
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

Review 3.  Clinical drug development for dementia with Lewy bodies: past and present.

Authors:  Garam Lee; Jeffrey Cummings; Boris Decourt; James B Leverenz; Marwan N Sabbagh
Journal:  Expert Opin Investig Drugs       Date:  2019-10-28       Impact factor: 6.206

Review 4.  Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.

Authors:  Katherine E McDonell; Cyndya A Shibao; Daniel O Claassen
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

5.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

Review 6.  Neurological Sleep Disorders and Blood Pressure: Current Evidence.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

7.  Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Josie-Anne Bertrand; Daphné Génier Marchand; Jacques Y Montplaisir
Journal:  Neurology       Date:  2015-02-13       Impact factor: 9.910

8.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.

Authors:  Ronald B Postuma; Alex Iranzo; Birgit Hogl; Isabelle Arnulf; Luigi Ferini-Strambi; Raffaele Manni; Tomoyuki Miyamoto; Wolfgang Oertel; Yves Dauvilliers; Yo-El Ju; Monica Puligheddu; Karel Sonka; Amelie Pelletier; Juan Santamaria; Birgit Frauscher; Smaranda Leu-Semenescu; Marco Zucconi; Michele Terzaghi; Masayuki Miyamoto; Marcus M Unger; Bertrand Carlander; Maria-Livia Fantini; Jacques Y Montplaisir
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

9.  Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.

Authors:  Birgit Frauscher; Poul Jennum; Yo-El S Ju; Ronald B Postuma; Isabelle Arnulf; Valerie Cochen De Cock; Yves Dauvilliers; Maria L Fantini; Luigi Ferini-Strambi; David Gabelia; Alex Iranzo; Smaranda Leu-Semenescu; Thomas Mitterling; Masayuki Miyamoto; Tomoyuki Miyamoto; Jacques Y Montplaisir; Wolfgang Oertel; Amélie Pelletier; Paolo Prunetti; Monica Puligheddu; Joan Santamaria; Karel Sonka; Marcus Unger; Christina Wolfson; Marco Zucconi; Michele Terzaghi; Birgit Högl; Geert Mayer; Raffaele Manni
Journal:  Neurology       Date:  2014-02-19       Impact factor: 9.910

Review 10.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.